14 Einträge gefunden

1. Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer

   1. Stein, Alexander
   2. Atanackovic, Djordje
   3. Hildebrandt, Bert
   4. Stübs, Patrick
   5. Brugger, Wolfram
   6. Hapke, Gunnar
   7. Steffens, Claus-Christoph

   2015 - Forschungsinformationssystem des UKE
2. A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer

   1. Bokemeyer, Carsten
   2. Stein, Alexander
   3. Ridwelski, Karsten
   4. Atanackovic, Djordje
   5. Arnold, Dirk
   6. Wöll, Ewald
   7. Ulrich, Alexis

   2015 - Forschungsinformationssystem des UKE
3. Acute psychological stress increases peripheral blood CD3+CD56+ natural killer T cells in healthy men: possible implications for the development and treatment of allergic and autoimmune disorders

   1. Atanackovic, Djordje
   2. Nowottne, Ulrike
   3. Freier, Eva
   4. Weber, Cora Stefanie
   5. Meyer, Sabrina
   6. Bartels, Katrin
   7. Hildebrandt, York

   2013 - Forschungsinformationssystem des UKE
4. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer

   1. Grob, Tobias J
   2. Hoenig, Tobias
   3. Clauditz, Till S
   4. Atanackovic, Djordje
   5. Koenig, Alexandra M
   6. Vashist, Yogesh K
   7. Klose, Hans

   2013 - Forschungsinformationssystem des UKE
5. CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives

   1. Berger, Lars Arne
   2. Riesenberg, Hendrik
   3. Bokemeyer, Carsten
   4. Atanackovic, Djordje

   2013 - Forschungsinformationssystem des UKE
6. Current standards and new trends in the primary treatment of colorectal cancer.

   1. Stein, Alexander
   2. Atanackovic, Djordje
   3. Bokemeyer, Carsten

   2011 - Forschungsinformationssystem des UKE
7. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

   1. Pabst, Caroline
   2. Zustin, Jozef
   3. Jacobsen, Frank
   4. Luetkens, Tim
   5. Kröger, Nicolaus
   6. Schilling, Georgia
   7. Bokemeyer, Carsten

   2010 - Forschungsinformationssystem des UKE
8. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

   1. Marx, Andreas
   2. Burandt, Eike Christian
   3. Choschzick, Matthias
   4. Simon, Ronald
   5. Yekebas, Emre F.
   6. Kaifi, Jussuf
   7. Mirlacher, Martina

   2010 - Forschungsinformationssystem des UKE
9. Autoantibodies against tumor-related antigens: incidence and biologic significance.

   1. Kobold, Sebastian
   2. Luetkens, Tim
   3. Cao, Yanran
   4. Bokemeyer, Carsten
   5. Atanackovic, Djordje

   2010 - Forschungsinformationssystem des UKE
10. Prognostic and diagnostic value of spontaneous tumor-related antibodies.

    1. Kobold, Sebastian
    2. Luetkens, Tim
    3. Cao, Yanran
    4. Bokemeyer, Carsten
    5. Atanackovic, Djordje

    2010 - Forschungsinformationssystem des UKE - frei zugänglich
11. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

    1. Kobold, Sebastian
    2. Hegewisch-Becker, Susanna
    3. Oechsle, Karin
    4. Jordan, Karin
    5. Bokemeyer, Carsten
    6. Atanackovic, Djordje

    2009 - Forschungsinformationssystem des UKE
12. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

    1. Atanackovic, Djordje
    2. Luetkens, Tim
    3. Hildebrandt, York
    4. Arfsten, Julia
    5. Bartels, Katrin
    6. Horn, Christiane
    7. Stahl, Tanja

    2009 - Forschungsinformationssystem des UKE
13. Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming.

    1. Atanackovic, Djordje
    2. Altorki, Nasser K
    3. Cao, Yanran
    4. Ritter, Erika
    5. Ferrara, Cathy A
    6. Ritter, Gerd
    7. Hoffman, Eric W

    2008 - Forschungsinformationssystem des UKE
14. Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma.

    1. Atanackovic, Djordje
    2. Blum, Inga
    3. Cao, Yanran
    4. Wenzel, Sören
    5. Bartels, Katrin
    6. Faltz, Christiane
    7. Hossfeld, Dieter Kurt

    2006 - Forschungsinformationssystem des UKE